Literature DB >> 27390274

High burden of prevalent tuberculosis among previously treated people in Southern Africa suggests potential for targeted control interventions.

Florian M Marx1, Sian Floyd2, Helen Ayles3, Peter Godfrey-Faussett4, Nulda Beyers5, Ted Cohen6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27390274      PMCID： PMC5512114          DOI： 10.1183/13993003.00716-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  15 in total

1.  HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers.

Authors:  P Sonnenberg; J Murray; J R Glynn; S Shearer; B Kambashi; P Godfrey-Faussett
Journal:  Lancet       Date:  2001-11-17       Impact factor: 79.321

2.  Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial.

Authors:  D W Fitzgerald; M Desvarieux; P Severe; P Joseph; W D Johnson; J W Pape
Journal:  Lancet       Date:  2000-10-28       Impact factor: 79.321

3.  High rates of recurrence in HIV-infected and HIV-uninfected patients with tuberculosis.

Authors:  Judith R Glynn; Jill Murray; Andre Bester; Gill Nelson; Stuart Shearer; Pam Sonnenberg
Journal:  J Infect Dis       Date:  2010-03       Impact factor: 5.226

Review 4.  The benefits to communities and individuals of screening for active tuberculosis disease: a systematic review.

Authors:  K Kranzer; H Afnan-Holmes; K Tomlin; J E Golub; A E Shapiro; A Schaap; E L Corbett; K Lönnroth; J R Glynn
Journal:  Int J Tuberc Lung Dis       Date:  2013-04       Impact factor: 2.373

5.  Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy?

Authors:  Gavin J Churchyard; Katherine Fielding; Salome Charalambous; John H Day; Elizabeth L Corbett; Richard J Hayes; Richard E Chaisson; Kevin M De Cock; Badara Samb; Alison D Grant
Journal:  AIDS       Date:  2003-09-26       Impact factor: 4.177

6.  Effect of household and community interventions on the burden of tuberculosis in southern Africa: the ZAMSTAR community-randomised trial.

Authors:  Helen Ayles; Monde Muyoyeta; Elizabeth Du Toit; Ab Schaap; Sian Floyd; Musonda Simwinga; Kwame Shanaube; Nathaniel Chishinga; Virginia Bond; Rory Dunbar; Petra De Haas; Anelet James; Nico C Gey van Pittius; Mareli Claassens; Katherine Fielding; Justin Fenty; Charalampos Sismanidis; Richard J Hayes; Nulda Beyers; Peter Godfrey-Faussett
Journal:  Lancet       Date:  2013-08-01       Impact factor: 79.321

7.  Burden of new and recurrent tuberculosis in a major South African city stratified by age and HIV-status.

Authors:  Robin Wood; Stephen D Lawn; Judy Caldwell; Richard Kaplan; Keren Middelkoop; Linda-Gail Bekker
Journal:  PLoS One       Date:  2011-10-10       Impact factor: 3.240

8.  High prevalence of tuberculosis in previously treated patients, Cape Town, South Africa.

Authors:  Saskia den Boon; Schalk W P van Lill; Martien W Borgdorff; Donald A Enarson; Suzanne Verver; Eric D Bateman; Elvis Irusen; Carl J Lombard; Neil W White; Christine de Villiers; Nulda Beyers
Journal:  Emerg Infect Dis       Date:  2007-08       Impact factor: 6.883

9.  ZAMSTAR, The Zambia South Africa TB and HIV Reduction Study: design of a 2 x 2 factorial community randomized trial.

Authors:  Helen M Ayles; Charalambos Sismanidis; Nulda Beyers; Richard J Hayes; Peter Godfrey-Faussett
Journal:  Trials       Date:  2008-11-07       Impact factor: 2.279

10.  Prevalence of tuberculosis, HIV and respiratory symptoms in two Zambian communities: implications for tuberculosis control in the era of HIV.

Authors:  Helen Ayles; Albertus Schaap; Amos Nota; Charalambos Sismanidis; Ruth Tembwe; Petra De Haas; Monde Muyoyeta; Nulda Beyers
Journal:  PLoS One       Date:  2009-05-19       Impact factor: 3.240
View more
  14 in total

1.  FAST implementation in Bangladesh: high frequency of unsuspected tuberculosis justifies challenges of scale-up.

Authors:  R R Nathavitharana; P Daru; A E Barrera; S M Mostofa Kamal; S Islam; M Ul-Alam; R Sultana; M Rahman; Md S Hossain; P Lederer; S Hurwitz; K Chakraborty; N Kak; D B Tierney; E Nardell
Journal:  Int J Tuberc Lung Dis       Date:  2017-09-01       Impact factor: 2.373

2.  Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis.

Authors:  Florian M Marx; Ted Cohen; Nicolas A Menzies; Joshua A Salomon; Grant Theron; Reza Yaesoubi
Journal:  Lancet Glob Health       Date:  2020-09       Impact factor: 26.763

3.  Treatment as prevention and other interventions to reduce transmission of multidrug-resistant tuberculosis.

Authors:  R R Nathavitharana; P Lederer; D B Tierney; E Nardell
Journal:  Int J Tuberc Lung Dis       Date:  2019-04-01       Impact factor: 2.373

4.  Clinical standards for the assessment, management and rehabilitation of post-TB lung disease.

Authors:  G B Migliori; F M Marx; N Ambrosino; E Zampogna; H S Schaaf; M M van der Zalm; B Allwood; A L Byrne; K Mortimer; R S Wallis; G J Fox; C C Leung; J M Chakaya; B Seaworth; A Rachow; B J Marais; J Furin; O W Akkerman; F Al Yaquobi; A F S Amaral; S Borisov; J A Caminero; A C C Carvalho; D Chesov; L R Codecasa; R C Teixeira; M P Dalcolmo; S Datta; A-T Dinh-Xuan; R Duarte; C A Evans; J-M García-García; G Günther; G Hoddinott; S Huddart; O Ivanova; R Laniado-Laborín; S Manga; K Manika; A Mariandyshev; F C Q Mello; S G Mpagama; M Muñoz-Torrico; P Nahid; C W M Ong; D J Palmero; A Piubello; E Pontali; D R Silva; R Singla; A Spanevello; S Tiberi; Z F Udwadia; M Vitacca; R Centis; L D Ambrosio; G Sotgiu; C Lange; D Visca
Journal:  Int J Tuberc Lung Dis       Date:  2021-10-01       Impact factor: 3.427

Review 5.  Closing gaps in the tuberculosis care cascade: an action-oriented research agenda.

Authors:  Ramnath Subbaraman; Tulip Jhaveri; Ruvandhi R Nathavitharana
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2020-01-11

6.  Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study.

Authors:  Jamilah Meghji; Maia Lesosky; Elizabeth Joekes; Peter Banda; Jamie Rylance; Stephen Gordon; Joseph Jacob; Harmien Zonderland; Peter MacPherson; Elizabeth L Corbett; Kevin Mortimer; Stephen Bertel Squire
Journal:  Thorax       Date:  2020-02-26       Impact factor: 9.139

7.  Risk of developing active tuberculosis following tuberculosis screening and preventive therapy for Tibetan refugee children and adolescents in India: An impact assessment.

Authors:  Kunchok Dorjee; Sonam Topgyal; Tenzin Tsewang; Tenzin Tsundue; Tenzin Namdon; Elizabeth Bonomo; Caroline Kensler; Dekyi Lhadon; Tsering Choetso; Tenzin Nangsel; Tsering Dolkar; Thupten Tsekyi; Chungdak Dorjee; Dawa Phunkyi; Tsetan D Sadutshang; Zorba Paster; Richard E Chaisson
Journal:  PLoS Med       Date:  2021-01-19       Impact factor: 11.069

8.  Tuberculosis control interventions targeted to previously treated people in a high-incidence setting: a modelling study.

Authors:  Florian M Marx; Reza Yaesoubi; Nicolas A Menzies; Joshua A Salomon; Alyssa Bilinski; Nulda Beyers; Ted Cohen
Journal:  Lancet Glob Health       Date:  2018-02-19       Impact factor: 26.763

9.  The Importance of Heterogeneity to the Epidemiology of Tuberculosis.

Authors:  James M Trauer; Peter J Dodd; M Gabriela M Gomes; Gabriela B Gomez; Rein M G J Houben; Emma S McBryde; Yayehirad A Melsew; Nicolas A Menzies; Nimalan Arinaminpathy; Sourya Shrestha; David W Dowdy
Journal:  Clin Infect Dis       Date:  2019-06-18       Impact factor: 9.079

10.  Risk factors for recurrent tuberculosis after successful treatment in a high burden setting: a cohort study.

Authors:  Patrick George Tobias Cudahy; Douglas Wilson; Ted Cohen
Journal:  BMC Infect Dis       Date:  2020-10-23       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.